Deva Holding A.S. (IST:DEVA)

Turkey flag Turkey · Delayed Price · Currency is TRY
57.85
+0.35 (0.61%)
Apr 25, 2025, 6:09 PM GMT+3
-20.54%
Market Cap 11.57B
Revenue (ttm) 15.46B
Net Income (ttm) 69.42M
Shares Out 200.02M
EPS (ttm) 0.35
PE Ratio 166.68
Forward PE n/a
Dividend 0.29 (0.50%)
Ex-Dividend Date Jun 25, 2024
Volume 250,572
Average Volume 435,207
Open 58.15
Previous Close 57.50
Day's Range 56.60 - 58.25
52-Week Range 53.55 - 106.00
Beta -0.03
RSI 42.85
Earnings Date Mar 4, 2025

About Deva Holding A.S.

Deva Holding A.S. engages in the manufacturing, marketing, and sales of pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory ... [Read more]

Sector Healthcare
Founded 1958
Employees 3,063
Stock Exchange Istanbul Stock Exchange
Ticker Symbol DEVA
Full Company Profile

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.

Financial Statements

News

There is no news available yet.